Prominent Companies - Uk Cell And Gene Therapy Research Challenges Industry

Gene therapy can be described as the transfer of genetic material mostly in a vector or carrier while cell therapy includes the transfer of cells with the applicable function into the patient’s body. In the broader sense, gene therapy involves introduction, withdrawel, or modification in genetic code with an aim of curing or treating a disease.

As of 2021, the U.K. Cell And Gene Therapy Research Challenges Market is estimated to be valued at U.S.$ 848 Million and is expected to exhibit a CAGR of 23.6% during the years (2021-2028)

Key Competitors in the Uk Cell And Gene Therapy Research Challenges Industry:

1) Sanofi S.A.

Sanofi S.A. is a multinational pharmaceutical company that engages in the research and development, of pharmacological products, in the prescription market. The firm cover therapeutic areas like Cardiovascular, central nervous system, diabetes, internal medicine. The company was founded in 973 and the headquarters are located in Paris, France. Products manufactured include Medications, Genetic drugs, Vaccines, Animal Health, etc.

In December, 2022 Sanofi expanded its collaboration with Innate Pharma, with Sanofi licensing a natural killer (NK) cell nagger program targeting B7H3 from Innate’s ANKET platform.

2) Pfizer Inc.

Pfizer Inc. is a pharmaceutical and biotechnology company based in America. It was founded in the year 1849. Pfizer manufactures and produces vaccines and medicine related to oncology, neurology, cardiology, and immunology. The corporation has produced various products that yield more than US$1 billion in annual revenue.

The company ranked 64^th on the Fortune 500 and 49^th on the Forbes Global 2000. The headquarters are located in New York City, U.S. and the products manufactured are sold worldwide. The company was founded by Charles Pfizer and Charles F. Erhart. 

In 2022, the company acquired Arena Pharmaceuticals for US$ 6.7 Billion. In October 2022, Pfizer completed the acquisition Biohaven Pharma for US$ 11.6 Billion.

3) Novartis AG

Novartis AG is a Swiss pharmaceutical corporation founded in March 1996 by Johann Rudolf The headquarters are located in Basel Switzerland, Cambridge, The United States of America and Massachusetts. It is one of the largest Pharma based company incorporated. The drugs manufactured are sold worldwide. Total revenue earned as of 2022 is US 50.545 billion dollars.

In June, 2022 Novartis completed the acquisition of Kedalion Therapeutics and its AcuStream technology.

4) Amgen Inc.

Amgen Inc. (Applied Molecular Genetics Inc.) is a biopharmaceutical company based in America. It is one of the world’s largest biotechnology company. The company was founded in the year 1980 on the 8^th of April. The headquarters are located in Thousand Oaks, California, U.S. The company sells its products worldwide and some of them include Aimovig, Enbrel, Prolia, Xgeva, Nplate etc. The company was founded by William K.

In August 2022, Amgen agreed to acquire ChemoCentryx, a company that makes Tavneos, a drug treatment for rare diseases. Amgen acquired the company for US$ 3.7 Billion

5) Biogen Inc.

Biogen Inc. is a multinational biotechnology company. The company mainly specializes in neurological diseases, they conduct researches and develop treatments for the conditions. The company was founded in the year 1978. The products sold include Avonex, Spinraza, Tecfidera etc. The headquarters are located in Cambridge, Massachusetts, U.S. The company was founded by Kenneth Murray, Philip Allen Sharp, Walter Gilbert, Heinz Schaller, Charles Weissmann.